Literature DB >> 12818264

Review article: inherited thrombophilia in inflammatory bowel disease.

Alfredo Papa1, Silvio Danese, Antonino Grillo, Giovanni Gasbarrini, Antonio Gasbarrini.   

Abstract

Individuals with inflammatory bowel disease frequently experience increased systemic thromboembolic complications, which represent an important cause of morbidity and mortality. Risk factors for thrombosis can be inherited or acquired. The most common inherited risk factors for thromboembolism are factor V Leiden mutation, G20210A mutation in the prothrombin gene, and homozygous C677T mutation in the methylenetetrahydrofolate reductase gene. In the last few years, a great amount of literature has focused on the prevalence of such genetic mutations and their role in determining thrombosis in IBD patients. In this review, we summarize the results of these studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818264     DOI: 10.1111/j.1572-0241.2003.07491.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  25 in total

1.  A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey.

Authors:  Serif Yilmaz; Kadim Bayan; Yekta Tüzün; Sabri Batun; Abdullah Altintaş
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

2.  Genotypes 677TT and 677CT+1298AC of methylenetetrahydrofolate reductase are associated with the severity of ulcerative colitis in central China.

Authors:  M Chen; B Xia; R M Rodriguez-Gueant; M Bigard; J-L Gueant
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

Review 3.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

4.  Involvement of serum retinoids and Leiden mutation in patients with esophageal, gastric, liver, pancreatic, and colorectal cancers in Hungary.

Authors:  Gyula Mózsik; György Rumi; András Dömötör; Mária Figler; Beáta Gasztonyi; Elod Papp; Alajos Pár; Gabriella Pár; József Belágyi; Zoltán Matus; Béla Melegh
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

Review 5.  Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Authors:  Franco Scaldaferri; Stefano Lancellotti; Marco Pizzoferrato; Raimondo De Cristofaro
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 6.  Inflammatory bowel disease: perioperative pharmacological considerations.

Authors:  Ajay Kumar; Moises Auron; Ashish Aneja; Franziska Mohr; Alok Jain; Bo Shen
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

7.  Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Andrew Cagan; Vivian S Gainer; Su-Chun Cheng; Tianxi Cai; Elizabeth Scoville; Gauree G Konijeti; Peter Szolovits; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-12       Impact factor: 11.382

Review 8.  Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.

Authors:  Danuta Owczarek; Dorota Cibor; Mikołaj K Głowacki; Tomasz Rodacki; Tomasz Mach
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 9.  Venous thromboembolism with inflammatory bowel disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

10.  Coagulation parameters in inflammatory bowel disease.

Authors:  Can Dolapcioglu; Aliye Soylu; Tulin Kendir; Ali Tuzun Ince; Hatice Dolapcioglu; Sevim Purisa; Cengiz Bolukbas; Haci Mehmet Sokmen; Remzi Dalay; Oya Ovunc
Journal:  Int J Clin Exp Med       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.